GCH1 and Parkinson disease: Previous works using DYT5-mouse models have shown that the involvement of the nigrostriatal system differed from that observed in PD models of the striatum striosome-matrix pattern of dopamine loss (35) and those with induction of functional alterations in dopamine receptors (36).